Company: BIAF
Filing Date: 2025-05-07
Form Type: 424B4
Source: 0001641172-25-008977
Chunk: 166

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-07
Form: 424B4
Chunk 166
---
 is against public policy as expressed in the Securities Act and is therefore unenforceable.

At present, there is no pending litigation or proceeding involving any of our directors or officers as to which indemnification is required or permitted, and we are not aware of any threatened litigation or proceeding that may result in a claim for indemnification.

| 81 |

<div align='center'>DESCRIPTION OF SECURITIES WE ARE OFFERING</div>

We are offering 7,784,904 shares of our Common Stock at a combined public offering price of $0.32 per share and accompanying May 2025 Warrant. We are also offering 2,371,346 Pre-Funded Warrants, at a combined public offering price of $0.313 per Pre-Funded Warrant and accompanying May 2025 Warrant, to those purchasers whose purchase of shares of our Common Stock in this offering would result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding shares of Common Stock following the consummation of this offering in lieu of the shares of Common Stock that would result in such excess ownership. Each share of our Common Stock or Pre-Funded Warrant is being sold together with one May 2025 Warrant to purchase one and one-half share of Common Stock. The shares of Common Stock and/or Pre-Funded Warrants and the accompanying May 2025 Warrants can only be purchased together in this offering but will be issued separately and will be immediately separable upon issuance. We are also registering the shares of our Common Stock issuable from time to time upon exercise of the Pre-Funded Warrants and Placement Agent Warrants offered hereby, as well as the shares of Common Stock that may be issuable pursuant to the Reverse Stock Split Adjustment contained in the May 2025 Warrants.

Common Stock

The description of our Common Stock under the section “Description of Our Securities—Common Stock” in this prospectus is incorporated herein by reference.

May 2025Warrants

The following summary of certain terms and provisions of the May 2025 Warrants included with the shares of Common Stock and the Pre-Funded Warrants that are being issued hereby is not complete and is subject to, and qualified in its entirety by, the provisions of the Warrant Agent Agreement between us and VStock Transfer, LLC, as Warrant Agent, and the form of the May 2025 Warrants